Mesenchymal stem cells for multiple sclerosis: Does neural differentiation really matter?

Current Stem Cell Research and Therapy

Volumn 6, Issue 1, 2011, Pages 69-72

  Uccelli, Antonio ^a,b   Morando, Sara ^a,b   Bonanno, Silvia ^a   Bonanni, Ivan ^a   Leonardi, Alessandro ^a   Mancardi, Gianluigi ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b Advanced Biotechnology Center ABC   (Italy)

Author keywords

Autoimmunity; Central nervous system; Experimental autoimmune encephalomyelitis; Mesenchymal stem cells; Multiple sclerosis

Indexed keywords

ARTICLE; CELL FATE; HUMAN; IMMUNOREGULATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MULTIPLE SCLEROSIS; NERVE CELL DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELL TRANSDIFFERENTIATION; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MULTIPLE SCLEROSIS;

EID: 79551674674     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488811794480744     Document Type: Article

References (41)

1. Joannides AJ, Chandran S. Human embryonic stem cells: an experimental and therapeutic resource for neurological disease. J Neurol Sci 2008; 265: 84-8.
2. Mancardi G, Saccardi R. Autologous haematopoietic stem-cell transplantation in multiple sclerosis. Lancet Neurol 2008; 7: 626-36.
3. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008; 8: 726-36.
4. Martino G, Pluchino S. The therapeutic potential of neural stem cells. Nat Rev Neurosci 2006; 7: 395-406.
5. Sacchetti B, Funari A, Michienzi S, et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 2007; 131: 324-36.
6. Horwitz E, Le Blanc K, Dominici M, et al. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 2005; 7: 393-5.
7. Uccelli A, Pistoia V, Moretta L. Mesenchymal stem cells: a new strategy for immunosuppression? Trends Immunol 2007; 28: 219-26.
8. Zappia E, Casazza S, Pedemonte E, et al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T cell anergy. Blood 2005; 106: 1755-61.
9. Zhang J, Li Y, Chen J et al. Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice. Exp. Neurol 2005; 195: 16-26.
10. Gerdoni E, Gallo B, Casazza S, et al. Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann Neurol 2007; 61: 219-27.
11. Bai L, Lennon DP, Eaton V, et al. Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia 2009; 57: 1192-203.
12. Gordon D, Pavlovska G, Glover CP, et al. Human mesenchymal stem cells abrogate experimental allergic encephalomyelitis after intraperitoneal injection, and with sparse CNS infiltration. Neurosci Lett 2008; 448: 71-3.
13. Kassis I, Grigoriadis N, Gowda-Kurkalli B, et al. Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis. Arch Neurol 2008; 65: 753-61.
14. Rafei M, Campeau P, Aguilar-Mahecha A, et al. Mesenchymal Stromal Cells Ameliorate EAE by Inhibiting CD4 Th17 T-cells in a CCL2-dependent Manner. J Immunol 2009; 182: 5994-6002.
15. Zhang J, Li Y, Lu M, et al. Bone marrow stromal cells reduce axonal loss in experimental autoimmune encephalomyelitis mice. J Neurosci Res 2006; 84: 587-95.
16. Crigler L, Robey RC, Asawachaicharn A, Gaupp D, Phinney DG. Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp Neurol 2006; 198: 54-64.
17. Pedemonte E, Benvenuto F, Casazza S, et al. The molecular signature of therapeutic mesenchymal stem cells exposes the architecture of the hematopoietic stem cell niche synapse. BMC Genomics 2007; 8: 65.
18. Lanza C, Morando S, Voci A et al. Neuroprotective Mesenchymal Stem Cells are endowed with a potent antioxidant effect in vivo. J Neurochem 2009; 110: 1674-84
19. Ohtaki H, Ylostalo JH, Foraker JE, et al. Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses. Proc Natl Acad Sci USA 2008; 105: 14638-43.
20. Kim YJ, Park HJ, Lee G, et al. Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action. Glia 2009; 57: 13-23.
21. Munoz JR, Stoutenger BR, Robinson AP, Spees JL, Prockop DJ. Human stem/progenitor cells from bone marrow promote neuro-genesis of endogenous neural stem cells in the hippocampus of mice. Proc Natl Acad Sci USA 2005; 102: 18171-6.
22. Akiyama Y, Radtke C, Kocsis J. Remyelination of the Rat Spinal Cord by Transplantation of Identified Bone Marrow Stromal Cells. J Neuroscience 2002; 22: 6623-30.
23. Rivera FJ, Couillard-Despres S, Pedre X, et al. Mesenchymal stem cells instruct oligodendrogenic fate decision on adult neural stem cells. Stem Cells 2006; 24: 2209-19.
24. Devine SM, Cobbs C, Jennings M, Bartholomew A, Hoffman R. Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into non-human primates. Blood 2003; 101: 2999-3001.
25. Li Y, Chen J, Chen XG et al. Human marrow stromal cell therapy for stroke in rat: Neurotrophins and functional recovery. Neurology 2002; 59: 514-23.
26. Ruster B, Gottig S, Ludwig RJ, et al. Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells. Blood 2006; 108: 3938-44.
27. Sordi V, Malosio ML, Marchesi F, et al. Bone marrow mesenchy-mal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 2005; 106: 419-27.
28. Spaggiari GM, Capobianco A, Becchetti S, Mingari MC, Moretta L. Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 2006; 107: 1484-90.
29. Prigione I, Benvenuto F, Bocca P, et al. Reciprocal interactions between human mesenchymal stem cells and gammadelta T cells or invariant natural killer T cells. Stem Cells 2009; 27: 693-702.
30. Eliopoulos N, Stagg J, Lejeune L, Pommey S, Galipeau J. Alloge-neic marrow stromal cells are immune rejected by MHC class I-and class II-mismatched recipient mice. Blood 2005; 106: 4057-65.
31. Kopen GC, Prockop DJ, Phinney DG. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci USA 1999; 96: 10711-6.
32. Sanchez-Ramos JR. Neural cells derived from adult bone marrow and umbilical cord blood. J Neurosci Res 2002; 69: 880-93.
33. Woodbury D, Schwarz EJ, Prockop DJ, Black IB. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 2000; 61: 364-70.
34. Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM, et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 2003; 425: 968-73.
35. Pluchino S, Gritti A, Blezer E, et al. Human neural stem cells ameliorate autoimmune encephalomyelitis in monkeys. Ann Neurol 2009; 66; 343-54.
36. Prockop DJ. Stemness does not explain the repair of many tissues by mesenchymal stem/multipotent stromal cells (MSCs). Clin Pharmacol Ther 2007; 82: 241-3.
37. Phinney DG, Prockop DJ. Concise Review: Mesenchymal Stem/Multi-Potent Stromal Cells (MSCs): The State of Transdif-ferentiation and Modes of Tissue Repair - Current Views. Stem Cells 2007; 25: 2896-902.
38. Lazarus HM, Koc ON, Devine SM, et al. Cotransplantation of HLA-Identical Sibling Culture-Expanded Mesenchymal Stem Cells and Hematopoietic Stem Cells in Hematologic Malignancy Patients. Biol Blood Marrow Transplant 2005; 11: 389-98.
39. Le Blanc K, Frassoni F, Ball L, et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008; 371: 1579-86.
40. Bang OY, Lee JS, Lee PH, Lee G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 2005; 57: 874-82.
41. Karussis D, Kassis I, Kurkalli BG, Slavin S. Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): a proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases. J Neurol Sci 2008; 265: 131-5.